Krishna Institute of Medical Sciences · NSE: KIMS · BSE: 543308
Q3 FY23 results · Oct–Dec 2022
Krishna Institute of Medical Sciences reported revenue from operations of ₹562.16 crore (up 42.8% from Q3 FY22) and net profit of ₹81.83 crore (down 2.8% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 562.16 | 393.57 | +42.8% | 564.07 | −0.3% |
| Other income | 6.45 | 2.39 | +169.7% | 9.20 | −29.9% |
| Total income | 568.61 | 395.96 | +43.6% | 573.28 | −0.8% |
| Profit before tax | 112.82 | 110.38 | +2.2% | 137.47 | −17.9% |
| Net profit for the period | 81.83 | 84.19 | −2.8% | 106.07 | −22.9% |
| Attributable to shareholders of the company | 76.14 | 81.17 | −6.2% | 97.11 | −21.6% |
| EPS, basic (₹) | 9.49 | 10.14 | −6.4% | 12.14 | −21.8% |
| Net margin (%) | 14.6 | 21.4 | 18.8 |
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 283.51 | 273.19 | +3.8% | 292.21 | −3.0% |
| Other income | 7.18 | 3.10 | +131.4% | 7.63 | −5.9% |
| Total income | 290.70 | 276.30 | +5.2% | 299.84 | −3.0% |
| Profit before tax | 85.56 | 89.84 | −4.8% | 83.78 | +2.1% |
| Net profit for the period | 64.47 | 66.99 | −3.8% | 61.20 | +5.3% |
| EPS, basic (₹) | 8.06 | 8.37 | −3.8% | 7.65 | +5.3% |
| Net margin (%) | 22.7 | 24.5 | 20.9 |
Consolidated
- Filed with BSE
- 10 Feb 2023, 11:05 IST
- Board meeting
- 09 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Feb 2023, 11:05 IST
- Board meeting
- 09 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE